Maxx Orthopedics announces FDA 510(k) clearance for Freedom® Metaphyseal Cone System
PR Newswire
NORRISTOWN, Pa., Nov. 15, 2025
The Freedom Metaphyseal Cone System expands Maxx Orthopedics' comprehensive Freedom® Revision Knee portfolio, which includes the Freedom® PCK and Freedom Titan™ PCK Knee Systems. The new system is indicated for cemented and uncemented applications and is designed to address tibial bone defects, metaphyseal reconstruction, and other complex revision indications
NORRISTOWN, Pa., Nov. 15, 2025 /PRNewswire-PRWeb/ -- Maxx Orthopedics, Inc. (Norristown, PA.), a rapidly expanding global orthopedics device company, today announces that it received US FDA clearance for the Freedom® Metaphyseal Cone System.
"The FDA clearance of the Freedom® Metaphyseal Cone System underscores our continued commitment to innovation and the advancement of revision knee technology," said Farzin Khaghani, Chief Commercial Officer at Maxx Orthopedics.
The Freedom Metaphyseal Cone System expands Maxx Orthopedics' comprehensive Freedom® Revision Knee portfolio, which includes the Freedom® PCK and Freedom Titan™ PCK Knee Systems. The new system is indicated for cemented and uncemented applications and is designed to address tibial bone defects, metaphyseal reconstruction, and other complex revision indications.
Manufactured from Ti6Al4V ELI titanium alloy, the Freedom Metaphyseal Cones feature an elliptical design that scales larger in the medial-lateral (ML) direction than the anterior-posterior (AP), optimizing implant fit and load distribution. A stepped geometry enhances proximal-distal stability, while a large internal diameter accommodates larger stem options. Wide relief slots are engineered to interface with the fins and keel of the Freedom Knee Tibial Baseplate, ensuring system compatibility.
Each cone incorporates a proprietary 3D-printed scaffold structure, approximately 1 mm thick, on the AP and ML margins. This structure replicates the size and porosity of cancellous bone, promoting biological fixation and stability in both cemented and press-fit configurations. "The FDA clearance of the Freedom® Metaphyseal Cone System underscores our continued commitment to innovation and the advancement of revision knee technology," said Farzin Khaghani, Chief Commercial Officer at Maxx Orthopedics. "This addition strengthens our product portfolio and provides surgeons with versatile, high-performance solutions to address the diverse needs of complex knee revision cases."
About Maxx Orthopedics, Inc. Maxx Orthopedics, Inc. is the manufacturer of the Freedom Knee System, Libertas Total Hip System, and Quick Recovery Solutions (QRS). We develop and market innovative orthopedic medical devices with a focus on providing state-of-the-art implants and related solutions designed that best restore patient mobility, while accommodating lifestyle, anatomical and economic needs. Find out more at www.maxxortho.com/ and follow us on LinkedIn, X, Instagram, and Facebook. Media contacts: Maxx Orthopedics, Inc. Donald Montgomery info@maxxortho.com
Media Contact
Donnie Montgomery, Maxx Orthopedics, 1 4843420092, donnie.montgomery@maxxortho.com, www.maxxortho.com
View original content to download multimedia:https://www.prweb.com/releases/maxx-orthopedics-announces-fda-510k-clearance-for-freedom-metaphyseal-cone-system-302616016.html
SOURCE Maxx Orthopedics
